ArticlePLOS global public health2025

Impact of fluoroquinolone resistance on the cost-effectiveness of empiric treatment for multidrug- or rifampicin-resistant tuberculosis.

Chaelin Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.